New York has overhauled its physician-oversight law, giving the state medical board more power, consumers more information, and doctors less confidentiality.
STOCKHOLM—Sunitinib used in tandem with docetaxel and prednisone appears to be safe and well tolerated in men with metastatic hormone-refractory prostate cancer (HRPC), investigators announced here at the 33rd Congress of the European Society of Medical Oncology.
Two nephrologists believe CKD is being overdiagnosed in the United States, particularly among the elderly. The physicians assert that the current National Kidney Foundation (NKF) Kidney Disease Outcome Initiative (K/DOQI) criteria for staging CKD include flaws, the most serious of which is the erroneous labeling of many elderly people as having CKD stage 3.
Researchers who studied prostate cancer patients treated with either robot-assisted laparoscopic radical prostatectomy (RALP) or retropubic radical prostatectomy (RRP) found that RRP patients were less likely to be dissatisfied with their treatment choice.